Indicated for the treatment of chronic Hepatitis C infection: Effective against Genotypes 1, 2, 3, and 4. Suitable for patients with or without compensated cirrhosis. Safe for patients coinfected with HIV.

Dosage and administration

The set contains 2 bottles (28 tabs each). ⚠️ CRITICAL DOSING INSTRUCTION: You must take TWO tablets daily (One Sofovir + One Daclahep). Take them together at the same time every day. Can be taken with or without food. 🚫 NEVER take monotherapy! Do not finish one bottle and then start the other. They must be taken concurrently to kill the virus.

🚫 AMIODARONE WARNING: Do not take with Amiodarone. This combination can cause severe, life-threatening bradycardia (slow heart rate). Other Contraindications: Pregnancy and breastfeeding. Children under 18 years. Co-administration with Rifampin or St. John's Wort (reduces cure rate).

Side effects are usually mild and transient: Fatigue and Headache. Nausea. HBV Reactivation: All patients should be screened for current or prior Hepatitis B infection before starting treatment, as reactivation may occur.

Sofovir + Daclahep — Sofosbuvir 400 mg + 60 mg, 28 + 28 pcs, Hetero

100% original product

Active ingredient

Sofosbuvir Daclatasvir

Manufacturer

Hetero

Dosage 400 mg + 60 mg

Dosage form Tablets

Tablets per pack 28 + 28

Sofovir + Daclahep Kit (Sofosbuvir 400mg & Daclatasvir 60mg)

Name: Sofovir + Daclahep
Brand: Hetero
SKU: PROD-49
Price: 3516 UAH
Availability: InStock

3516₴ ~~4395₴~~ -20%

Sofovir + Daclahep (Kit) is a combination therapy for Hepatitis C, consisting of two separate bottles: Sofosbuvir (400 mg) and Daclatasvir (60 mg).

Manufacturer: Hetero Healthcare (India). These are the generic equivalents of Sovaldi and Daklinza.

The "Twin" Therapy:

This regimen attacks the virus from two angles. Sofosbuvir inhibits the NS5B polymerase, while Daclatasvir inhibits the NS5A protein. Together, they stop viral replication and assembly, offering a cure rate of over 95% across multiple genotypes.

✅ Versatility: Considered a pan-genotypic solution (Treats Genotypes 1, 2, 3, and 4).

Indicated for the treatment of chronic Hepatitis C infection:

Effective against Genotypes 1, 2, 3, and 4.
Suitable for patients with or without compensated cirrhosis.
Safe for patients coinfected with HIV.

The set contains 2 bottles (28 tabs each).

⚠️ CRITICAL DOSING INSTRUCTION:

You must take TWO tablets daily (One Sofovir + One Daclahep).

Take them together at the same time every day.
Can be taken with or without food.
🚫 NEVER take monotherapy! Do not finish one bottle and then start the other. They must be taken concurrently to kill the virus.

🚫 AMIODARONE WARNING:

Do not take with Amiodarone. This combination can cause severe, life-threatening bradycardia (slow heart rate).

Other Contraindications:

Pregnancy and breastfeeding.
Children under 18 years.
Co-administration with Rifampin or St. John's Wort (reduces cure rate).

Side effects are usually mild and transient:

Fatigue and Headache.
Nausea.
HBV Reactivation: All patients should be screened for current or prior Hepatitis B infection before starting treatment, as reactivation may occur.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 12.03.2026